These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7740719)

  • 21. Demand-side policies to encourage the use of generic medicines: an overview.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Supervision of distribution and use of veterinary drugs in Schleswig-Holstein].
    Bettin U
    Dtsch Tierarztl Wochenschr; 1996 Jul; 103(7):240-3. PubMed ID: 8998935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
    Menghaney L
    Indian J Med Ethics; 2010; 7(2):97-100. PubMed ID: 20432882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription of generic drugs--is it really a smart initiative?
    Dabas A; Shah D
    Indian Pediatr; 2014 Oct; 51(10):842-3. PubMed ID: 25362027
    [No Abstract]   [Full Text] [Related]  

  • 25. Retailing policies for generic medicines.
    Narciso S
    Int J Health Care Finance Econ; 2005 Jun; 5(2):165-90. PubMed ID: 15912315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHO tries to tackle problem of counterfeit medicines in Asia.
    Pincock S
    BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615319
    [No Abstract]   [Full Text] [Related]  

  • 27. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Wiberg CC
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15851759
    [No Abstract]   [Full Text] [Related]  

  • 28. India combats confusion over counterfeit drugs.
    Chatterjee P
    Lancet; 2010 Feb; 375(9714):542. PubMed ID: 20191673
    [No Abstract]   [Full Text] [Related]  

  • 29. Forthcoming changes in the misuse of drugs legislation.
    Edwards BR; Knifton A
    Vet Rec; 1986 Mar; 118(13):350. PubMed ID: 3705380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nevertheless control of documentation of generic drugs?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1669. PubMed ID: 17571110
    [No Abstract]   [Full Text] [Related]  

  • 31. Is India ready to lead the battle for fair access to medicines?
    Lancet Oncology
    Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313
    [No Abstract]   [Full Text] [Related]  

  • 32. In the name of safety.
    Parish C
    Nurs Stand; 2002 Oct 30-Nov 5; 17(7):12. PubMed ID: 12452078
    [No Abstract]   [Full Text] [Related]  

  • 33. India's patent laws under pressure.
    Roderick P; Pollock AM
    Lancet; 2012 Sep; 380(9846):e2-4. PubMed ID: 22988579
    [No Abstract]   [Full Text] [Related]  

  • 34. [Should we accept defective copies?].
    Ostholm I
    Lakartidningen; 1993 Oct; 90(43):3747-8. PubMed ID: 8231521
    [No Abstract]   [Full Text] [Related]  

  • 35. [On a project for regulation of supply and usage of veterinary drugs].
    Gounelle de Pontanel H
    Bull Acad Natl Med; 1968 Oct; 152(26):450-2. PubMed ID: 4890829
    [No Abstract]   [Full Text] [Related]  

  • 36. Confusion over counterfeit drugs in Uganda.
    Anderson T
    Lancet; 2009 Jun; 373(9681):2097-8. PubMed ID: 19551913
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 38. The global impact of Indian generics on access to health.
    Ravinetto RM; Dorlo TP; Caudron JM; Prashanth NS
    Indian J Med Ethics; 2013; 10(2):118-20. PubMed ID: 23697493
    [No Abstract]   [Full Text] [Related]  

  • 39. Shipman inquiry recommends tighter rules on controlled drugs.
    Dyer C
    BMJ; 2004 Jul; 329(7459):188. PubMed ID: 15271810
    [No Abstract]   [Full Text] [Related]  

  • 40. Determinants of generic entry in the regulated Taiwanese prescription drug market.
    Liu YM; Cheng JS
    Health Policy; 2012 Dec; 108(2-3):228-35. PubMed ID: 23020970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.